Quantitative analysis of tumor vascular targeting: Effects of endostatin in a phase I clinical trial.

被引：0
作者：
Davis, DW
Mullani, N
Hess, KR
Tseng, J
O'Reilly, M
Herbst, RS
Abbruzzese, JL
McConkey, DJ
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas, Sch Med, Houston, TX USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
286
引用
收藏
页码：3711S / 3711S
页数：1
相关论文
共 50 条
[21]   Immunological evaluation of personalized peptide vaccination for patients with malignant glioma: The results of a clinical phase I trial. [J].
Yamanaka, R. ;
Yajima, N. ;
Mine, T. ;
Yamada, A. ;
Shigemor, M. ;
Ito, K. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :64S-64S
[22]   Multimodal fluorescence-guided surgery of colorectal peritoneal metastases, a phase I/II clinical trial. [J].
de Gooyer, Jan-Marie ;
Elekonawo, Fortune ;
Bremers, Andre J. A. ;
Boerman, Otto ;
Rijpkema, Mark ;
de Wilt, Johannes H. W. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[23]   Fosrenol™ (lanthanum carbonate) is well tolerated in patients requiring hemodialysis:: Results of a phase I clinical trial. [J].
Sack, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 :386A-386A
[24]   Imaging dopamine transporters with I-123 altropane: Preliminary report of a phase 1 clinical trial. [J].
Mercier, G ;
Pourdehnad, M ;
Alavi, A ;
Reivich, M ;
Mozley, D ;
Fischman, A ;
Lanser, M .
JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) :214P-214P
[25]   Vascular endothelial growth factor and the effects of endostatin on the inhibition of tumor angiogenesis in treating hepatocarcinomas [J].
邓靖宇 ;
何生 .
中华肝脏病杂志, 2005, (04) :85-86
[26]   Disparate effects of endostatin on tumor vascular perfusion and hypoxia in two murine mammary carcinomas [J].
Fenton, BM ;
Paoni, SF ;
Grimwood, BG ;
Ding, I .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (04) :1038-1046
[27]   Ixazomib for Desensitization (IXADES): Results of a Phase II Clinical Trial. [J].
Wilson, N. ;
Reese, S. R. ;
Ptak, L. ;
Aziz, F. ;
Parajuli, S. ;
Jucaud, V. ;
Denham, S. ;
Mishra, A. ;
Hematti, P. ;
Djamali, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 :508-508
[28]   Targeting tumor lectins, a galactmannan derivative, shows promising results in pre-clinical and phase I clinical trial in patients with refractory solid tumors [J].
Jyotsna, F. ;
Abubakr, Y. ;
Perez, R. ;
Zalupski, M. ;
Pike, M. ;
Platt, D. ;
Zomer, E. ;
Klyosov, A. .
TUMOR BIOLOGY, 2006, 27 :24-24
[29]   Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer [J].
Sebastian Strieth ;
Christoph Dunau ;
Kristina Kolbow ;
Ruth Knuechel ;
Uwe Michaelis ;
Hannelore Ledderose ;
Martin E. Eichhorn ;
Donata Strelczyk ;
Uta Tschiesner ;
Barbara Wollenberg ;
Marc Dellian .
European Archives of Oto-Rhino-Laryngology, 2013, 270 :1481-1487
[30]   Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer [J].
Strieth, Sebastian ;
Dunau, Christoph ;
Kolbow, Kristina ;
Knuechel, Ruth ;
Michaelis, Uwe ;
Ledderose, Hannelore ;
Eichhorn, Martin E. ;
Strelczyk, Donata ;
Tschiesner, Uta ;
Wollenberg, Barbara ;
Dellian, Marc .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (04) :1481-1487
12345